Here are relevant reports on : personalized-products-market
-
Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030
The global mice model market, valued at US$1.53 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials; the rising demand for personalized medicine in oncology; and advancements in genetic engineering.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Retail Market by Solution (Personalized Product Recommendation, Visual Search, Virtual Stores, Virtual Customer Assistant, CRM), Type (Generative AI, Other AI), End-user (Online, Offline) - Global Forecast to 2030
The AI in retail market is projected to reach USD 164.74 billion by 2030, at a CAGR of 32.0% during the forecast period. Microsoft (US), IBM (US), Google (US), Amazon (US), Oracle (US), Salesforce (US), NVIDIA (US), SAP (Germany), ServiceNow (US), Accenture (Ireland), Infosys (India), Alibaba (China), Intel (US), AMD (US), Fujitsu (Japan), Capgemini (France), TCS (India), Talkdesk (US), Symphony AI (US), Bloomreach (US), C3.AI (US), Visenze (Singapore), Pathr.ai (US), Vue.AI (US), Nextail (Spain), Daisy Intelligence (Canada), Cresta (US), Mason (US), Syte (Israel), Trax (Singapore), Feedzai (US), and Shopic (Israel).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application (Personalized Storage, Clinical (Autoimmune, Hematopoietic Disorders), Research) - Global Forecasts to 2023
The global stem cell banking market is projected to reach USD 9.30 Billion by 2023, at a CAGR of 8.2%. Major players in the global stem cell banking market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Prescriptive Analytics Market by Component, Application (Customer Retention and Engagement and Personalized Recommendation), Deployment Mode, Organization Size, Vertical, Capability, and Region (2022 - 2026)
The prescriptive analytics market size is projected to reach USD 14.3 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 24.0% during the forecast period. The major vendors in the global prescriptive analytics market include IBM (US), Microsoft (US), Salesforce (US), SAP (Germany), SAS Institute (US), Talend (US), FICO (US), Ayata (US), Altair (US), Alteryx (US), TIBCO (US), Sisense(US) Happiest Minds (India), Zebra (England), Infor (US), RapidMiner (US), Logi Analytics (US), Qlik (US), River Logic (US), Frontline Systems (US), Netformx (US), Mitek Analytics (France), and Panorat.IO (US).
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization [Array-based, Standard]), Application (Cancer, Personalized Medicine) - Global Forecast to 2030
The global molecular cytogenetics market, valued at US$0.97 billion in 2024, stood at US$1.02 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$1.43 billion by the end of the period. The market growth is fueled by increasing incidence of cancer & genetic disorders and rising usage of molecular cytogenetics in clinical pathology testing.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Nutraceuticals & Dietary Supplements Industry Outlook (2024-2025) – Personalized Nutrition, Sustainability, and Technological Advancements Shaping the Future of Wellness
The nutraceuticals & dietary supplements industry is undergoing transformative shifts driven by sustainability, technology, and innovation. These changes focus on improving product efficacy, personalization, and consumer engagement, signaling a move toward more sustainable and technologically advanced solutions.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Acerola Extract Market by Application (Meat Products, Bakery Products, Confectioneries, Dairy & Frozen Desserts, and Beverages), Form (Dry and Liquid), Nature (Conventional and Organic), Functionality and Region - Global Forecast to 2026
The global acerola extract market is expected to grow from USD 16 Million in 2021 to USD 24 Million by 2026, at a compound annual growth rate (CAGR) of 7.6% during the forecast period. The leading players such as DSM (Netherlands), Kemin Industries, Inc. (US), Dohler GmbH (Germany), The Green Labs LLC (US), Diana Food S.A.S. (France), Naturex S.A. (France), NutriBotanica (Brazil), Handary SA (Belgium), Foodchem International Corporation (China), and Nichirei do Brasil Agrícola Ltda. (Brazil).
- Published: February 2022
- Price: $ 4950
- TOC Available:
-
Gastrointestinal Products Market | Gastroenterology Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Global Forecast to 2029
The global gastrointestinal products market, valued at US$13.8 million in 2023, stood at US$14.7 million in 2024 and is projected to advance at a resilient CAGR of 6.1% from 2024 to 2029, culminating in a forecasted valuation of US$19.7 million by the end of the period. Market growth can be attributed to the growing prevalence of gastrointestinal diseases such as Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and colorectal cancer, which drives the demand for diagnostic and therapeutic products.
- Published: August 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
